CDMO CROs

Global leader in drug delivery technologies and development solutions. Catalent provides formulation, development, and manufacturing services for pharmaceuticals, biologics, and consumer health products.

Leading CDMO providing custom development and manufacturing for the pharmaceutical and biotech industries. Lonza specializes in biologics, cell and gene therapy, and small molecule manufacturing.

Biologics CDMO providing GMP manufacturing of viral vaccines, recombinant proteins, and gene therapy vectors from BSL-2/3 facilities, with particular expertise in infectious disease and oncology.

Global CDMO with 30+ years delivering development and manufacturing for biologics, cell therapies, viral vectors, and mRNA across US, European, and Asian facilities.

Contract research and manufacturing organization offering drug discovery, API synthesis, analytical development, and formulation services to global pharma and biotech.

European CDMO with 13 production sites across seven countries providing oral solid dose, softgel, and sterile manufacturing for pharma and biotech clients.

Munich-headquartered European CDMO providing development and manufacturing of solid oral dosage forms, capsules, and effervescent tablets with 12 GMP manufacturing sites across Europe.

San Diego-based CDMO providing small and large molecule API manufacturing, oligonucleotide synthesis, and ADC conjugation services from pre-clinical through commercial scale.

CDMO providing custom API development and manufacturing, solid dose and sterile formulation, analytical testing, and clinical and commercial supply from multiple US facilities.

US-based contract pharmaceutical company providing tableting, encapsulation, powder blending, packaging, and clinical supply manufacturing services for oral solid dosage forms.

CDMO headquartered in Northern Ireland providing GMP API synthesis, drug product development, clinical trial supply manufacturing, and biomarker services across North America and Europe.

Gene therapy and viral vector CDMO in Columbus, Ohio, with 20+ years of leadership and 500+ GMP drug substance batches produced for rare and ultra-rare disease programs.

Belgian CDMO providing integrated drug substance and drug product development from early-phase API synthesis through formulation, analytical development, and GMP manufacturing.

Chinese CDMO providing pharmaceutical development and manufacturing services from drug discovery to commercialization, known as a long-term supplier to major pharmaceutical companies including Pfizer.

Dr. Reddy's wholly-owned integrated CRO and CDMO for small molecules and biologics, combining 650+ Indian scientists with GMP manufacturing in the UK, Mexico, and India.

Chinese CDMO specializing in custom synthesis of building blocks, advanced intermediates, and reference compounds for global pharmaceutical R&D, with a catalog of over 40,000 compounds.

Indian biopharmaceutical company providing biosimilar development, contract manufacturing, and clinical research services with GMP manufacturing facilities for biologics and biosimilars.

Swiss CDMO providing integrated drug substance and drug product development services including API synthesis, process development, and highly potent compound manufacturing.

CMIC Group's contract manufacturing arm providing GMP drug product manufacturing, formulation development, and packaging services from Japanese facilities.

Leading CDMO providing API development and manufacturing services including custom synthesis, generic APIs, and advanced intermediates from facilities across the US and Europe.

South Korean biopharmaceutical company providing biosimilar development and cGMP biologics manufacturing with one of the largest mammalian cell culture facilities in the world.

European CDMO network with 11 GMP facilities providing integrated API, drug product, and packaging services from pre-clinical through commercial scale including peptides, lipids, and injectables.

Swiss CDMO providing API synthesis, lipid nanoparticle manufacturing, and peptide production, known for large-scale mRNA lipid supply and complex pharmaceutical intermediates.

Labcorp's contract development and manufacturing arm providing formulation development, analytical services, stability testing, and clinical trial manufacturing for small molecules and biologics.

CDMO offering integrated drug discovery, development, and manufacturing services including API production, drug product manufacturing, and analytical services from facilities in the US, Europe, and India.

Swiss specialty CDMO focused on exclusive custom synthesis and manufacturing of hazardous chemical reactions, energetic compounds, and complex API intermediates for pharma and fine chemical clients.

US CDMO providing drug substance manufacturing, fill-finish, and device assembly services for biologics, vaccines, and cell/gene therapy products.

CDMO division of Eurofins providing process development, analytical development, and GMP manufacturing for biopharmaceutical products including monoclonal antibodies and recombinant proteins.

Dutch CDMO specialising in controlled substance manufacturing and schedule I-V API synthesis for clinical trial and commercial supply under DEA and EMA licences.

Top-tier biologics CDMO offering cell culture, microbial fermentation, and cell and gene therapy manufacturing across US sites supporting 128+ regulatory approvals.

Hungarian pharmaceutical company's CDMO division offering API synthesis, steroids manufacturing, and hormone product development from GMP-certified facilities.

German CDMO specialising in sterile liquid fill-finish, lyophilisation, and oral solid dosage manufacturing for clinical and commercial supply.

Australian CDMO providing API manufacturing, sterile fill-finish, and pharmaceutical development services from TGA-licensed and FDA-registered facilities in Melbourne.

Spanish CDMO specialising in oral solid dosage form development, hot-melt extrusion, spray drying, and GMP clinical supply manufacturing for early-phase programmes.

US biologics CDMO providing cell line development, process development, cGMP manufacturing, and analytical services for monoclonal antibodies, recombinant proteins, and gene therapy products.

Korean CDMO providing development and GMP manufacturing of solid oral dosage forms, injectables, and biosimilars, with FDA and EMA-inspected facilities serving global markets.

Hyderabad-based pharma company with integrated CDMO and API manufacturing capabilities, offering contract development and manufacturing of active pharmaceutical ingredients and finished dosage forms.

Specialist topical and transdermal formulation development CRO and CDMO offering dermal PK, in vitro permeation, bioequivalence, and formulation development services.

North Carolina-based CDMO specialising in oral solid dosage formulation development, analytical services, and cGMP clinical supply manufacturing for Phase I-III.

Specialist CDMO for cell and gene therapy products offering GMP clinical and commercial manufacturing and development solutions for ATMPs from German, US, and Japanese facilities.

Tel Aviv-based Israeli pharmaceutical group with CDMO division providing contract development and manufacturing of solid, semi-solid, and liquid dosage forms for domestic and export markets.

French CDMO specialising in topical, semi-solid, and liquid pharmaceutical manufacturing for clinical trial supply and commercial production.

Tokyo-based CRO and CDMO providing contract manufacturing of injectable formulations, lyophilized products, and sterile fills for Japanese and international pharmaceutical clients.

Specialized CDMO focused exclusively on sustained-release long-acting injectable formulation development, aseptic fill-finish, and lyophilization.

Gene therapy-focused CDMO providing viral vector manufacturing for adeno-associated virus (AAV) gene therapies, acquired by Catalent to expand biologics capabilities.

Major global CDMO providing end-to-end pharmaceutical development and manufacturing services including drug substance, drug product, and commercial manufacturing under the Thermo Fisher Scientific umbrella.

Jordanian CDMO providing contract manufacturing of solid oral dosage forms, semi-solids, and liquids for export markets across the Middle East, Africa, and CIS countries.

Missouri-based CDMO providing oral solid dosage development and manufacturing including tablets, capsules, sachets, and effervescent forms from R&D through commercial scale.

Greek CDMO specialising in long-acting injectable (LAI) and controlled-release oral solid dosage development and manufacturing for complex generics and NCEs.

Global CDMO offering end-to-end pharmaceutical development and manufacturing including API synthesis, oral solid dose, sterile fill-finish, and antibody-drug conjugate manufacturing.

Chinese CDMO providing API development and manufacturing services including custom synthesis, process development, and commercial-scale production from multiple GMP-certified facilities.

Durham-based CDMO using proprietary ARCUS genome editing technology to develop and manufacture next-generation allogeneic cell and gene therapy programs.

Translational pharmaceutics CRO/CDMO uniquely combining formulation development and clinical pharmacology under one roof, accelerating drug development timelines by running formulation and clinical testing simultaneously.

Leading CDMO providing pharmaceutical manufacturing services including development, scale-up, and commercial production of oral solids, sterile products, and complex formulations.

Uppsala-based Swedish CDMO providing pharmaceutical development, manufacturing, and sterile fill-finish services with expertise in complex injectables and lyophilized products.

US-based biomanufacturing CDMO founded in 2020 delivering end-to-end development and manufacturing for biologics, mRNA, and cell and gene therapy across a domestic facility network.

Contract research organization providing discovery, preclinical, and development chemistry services including API synthesis, safety pharmacology, and medicinal chemistry.

Cell and gene therapy CDMO with purpose-built cGMP facilities in Edinburgh and Hopkinton, Massachusetts, supporting clinical and commercial advanced therapy programs.

Global CDMO with integrated small molecule, biologics, and gene therapy manufacturing including proprietary viral vector platforms across the US, Europe, and Asia.

Hyderabad-based Indian CDMO providing integrated drug discovery, development, and manufacturing services with capabilities spanning medicinal chemistry through commercial API supply.

South Korean biosimilar developer and CDMO providing biologics development, manufacturing, and analytical services with a portfolio of approved biosimilar products across global markets.

Leading CDMO providing end-to-end biopharmaceutical manufacturing services including cell line development, process development, and commercial manufacturing at massive scale.

ASX-listed Taiwanese CDMO providing world-class API synthesis, finished dose form manufacturing, and clinical packaging from GMP facilities in the Southern Taiwan Science Park.

Leading Chinese gene therapy CDMO providing lentiviral, adenoviral, and AAV vector manufacturing services along with custom cell line development for preclinical and clinical-grade production.

Global clinical supply packaging and distribution company providing clinical trial materials management, packaging, labeling, and worldwide distribution from facilities in the US and Europe.

Ireland-based specialty pharmaceutical development group providing formulation, analytical, and clinical supply services for oral, topical, and injectable dosage forms.

Indiana-based aseptic fill-finish CDMO specialising in small-batch sterile injectable manufacturing for cell therapies, gene therapies, and biologics.

Chinese CRO and CDMO providing drug discovery chemistry, DMPK, analytical services, and clinical trial manufacturing from Shanghai and Chengdu operations.

UK-based CDMO specialising in inhaled drug product development including dry powder inhalers, metered dose inhalers, and nasal spray formulations.

US-German CDMO specialising in viral vector and oncolytic virus manufacturing for gene therapy and immuno-oncology clinical programmes.

Maryland-based cell therapy development company providing iPSC-derived cell therapy manufacturing, process development, and analytical services for clinical-stage gene and cell therapy programs.

WuXi AppTec's cell and gene therapy division providing GMP viral vector manufacturing, cell therapy manufacturing, and plasmid DNA production from US and China facilities.

Global biologics CDMO providing end-to-end solutions for biologics drug development and manufacturing including monoclonal antibodies, bispecific antibodies, ADCs, and cell and gene therapies.

WuXi AppTec's pharmaceutical development and manufacturing arm providing API process development, formulation development, analytical services, and GMP manufacturing from China and US facilities.

Independent pharmaceutical development services company in Basel providing drug formulation development, analytical development, and stability testing for injectable and biopharmaceutical products.